The Fatty Acid Composition of Blood Plasma and Arterial Wall in Atherosclerosis

Alexander N. Osipenko*

 A. Kuleshov State University of Mogilev, Mogilev, Belarus

*Corresponding author: Alexander N. Osipenko, A. Kuleshov State University of Mogilev, 3/45, Surganova str., 212026, Mogilev, Belarus. Tel: 375-29-1314671, 375-29-5452303. E-mail:


The aim of this study was to assess the fatty acid balance in the blood plasma, in the fragments of the intact vessels and the vessels showing signs of atherosclerosis.

Material and Methods: The article presents the results of the examination of the blood plasma samples of patients with coronary heart disease and coronary atherosclerosis. The control group consisted of 16 healthy individuals. Also, the fragments of the abdominal aorta and the common carotid artery with varying degrees of atherosclerotic lesions were studied. Fatty acid analysis was conducted using capillary gas-liquid chromatography.

Results: A reduction in the relative linoleic acid level with an increase in almost all the saturated fatty acids and polyunsaturated dihomo-γ-linolenic acid in the plasma was noted in patients with coronary heart disease and atherosclerosis. The relationships between certain fatty acids in patients with atherosclerosis and myocardial ischemia showed changes. In patients with atherosclerosis, a marked imbalance was observed between the monounsaturated and correspondingly the saturated fatty acids (with the same number of carbon atoms) in the abdominal aorta with significant atherosclerotic lesions, as well as in the intact common carotid arteries. These disorders are probably related to the relatively low content of the linoleic acid in the blood plasma. The reasons for the increased activity of the fatty acid synthase in vessels with significant atherosclerotic lesions are described. It is concluded that most of the fatty acids of the plaque were formed due to the synthetic processes in the smooth muscle cells, and not as a result of their intake from the blood plasma.

atherosclerotic plaque; coronary heart disease; abdominal aorta; common carotid artery.
  1. Attie AD. Atherosclerosis Modified. J Circ Res 2001; 89: 102-4.
  2. Singh RB, Mengi SA, Xu YJ, Arneja AS, Dhalla NS. Pathogenesis of atherosclerosis: a multifactorial process. J Exp Clin Cardiol 2002; 7 (1): 40–53.
  3. Katz SS, Shipley GG, Small DM. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. Clin Invest 1976; 58 (1): 200-11.
  4. Williams KJ, Tabas I. The Response-to-Retention Hypothesis of Early Atherogenesis. J Arterioscler Thromb Vasc Biol 1995; 15 (5): 551–61.
  5. Vance DE, Vance JE. Biochemistry of Lipids, Lipoproteins and Membranes, 5th ed. Amsterdam: Elsevier, 2008.
  6. Pasterkamp G, van der Steen A.F. Intraplaque Hemorrhage: An Imaging Marker for Atherosclerotic Plaque Destabilization? Thromb. Vasc. Biol. 2012, 32 (2):167-168.
  7. Clair RW, Lofland HB, Clarkson TB. Composition and synthesis of fatty acids in atherosclerotic aortas of the pigeon. J Lipid Res 1968; 9: 739-47.
  8. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. J Circulation 1995; 92: 1355-74.
  9. Titov VN, Lisitsyn DM. Fatty acids. Physical chemistry, biology and medicine. Moscow–Tver: Triada, 2006. [in Russian].
  10. Kates M. Techniques of lipidology: Isolation, analysis and identification of lipids. New York: American Elsevier Pub. Co., 1972.
  11. Bezuglov VV, Konovalov SS. Lipids and Cancer. Essays on lipidology of the oncology Process. St. Petersburg: Prime–EVROZNAK, 2009. [in Russian].
  12. Chakravarty B, Gu Z, Chirala SS, Wakil SJ, Quiocho FA. Human fatty acid synthase: Structure and substrate selectivity of the thioesterase domain. J PNAS 2004; 101: 15567-72.
  13. Browne CD, Hindmarsh EJ, Smith JW. Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor. J FASEB 2006; 20: 2027-35.
  14. Kingsbury KJ, Brett C, Stovold R, Chapman A, Anderson J, Morgan DM. Abnormal fatty acid composition and human atherosclerosis. J Postgrad Med 1974; 50 (585): 425–40.

The fully formatted PDF version is available.

Download Article

Int J Biomed. 2012; 2(4):291-295. © 2012 International Medical Research and Development Corporation. All rights reserved.